Replies to post #9849 on Intellipharmaceutics International Inc. (IPCI)

[nccmtt]

to answer your question three clues are in my head
TEVA has problems with Focalin
IPCI has revised the agreement with PAR
The 5mg is still technically an ANDA

...so...

IPCI will produce branded Focalin TEVA?

Matteo

[AngeloFoca]

Yeah I was wondering what drug it was they partnered on

My guess, and it's only a guess... is it's Seroquel XR - which I believe IPCI has first to file exclusivity on most if not ALL the strenths.

6 months of no competition on a Billion $ drug should bring in over $100 million, and entrench them with distributors.

I believe Seroquel goes generic next year (2016)

I also believe this is the tip of the iceberg... TEVA is huge in the generic space... but they've wanted for years to increase their presence in the Branded drugs field which is far more profitable.

As I've been saying for 2 years... the generics keep the doors open, and Seroquel will be real sweet... but it's all about Rexista and Regabatin.

One more time - 20K shares today will make you a millionaire in 3 to 5 years.